🇺🇸 FDA
Patent

US 8883781

Thienopyrimidines useful as modulators of ion channels

granted A61PA61P1/04A61P1/06

Quick answer

US patent 8883781 (Thienopyrimidines useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P1/04, A61P1/06, A61P1/16, A61P1/18